NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)

This opportunity is for multi-site exploratory and confirmatory clinical trials focused on promising interventions, biomarker or outcome measure validation studies, and ancillary studies designed to add scientific aims to active studies being conducted within StrokeNet. Successful applicants will collaborate and conduct the study within the NIH StrokeNet infrastructure. The NIH StrokeNet National Coordinating Center (NCC) will work with the successful applicant to implement the proposed study efficiently, and the National Data Management Center (NDMC) will provide statistical and data management support. • The study will focus on stroke prevention, treatment, and recovery. • The NIH StrokeNet infrastructure will be used to conduct the study. • The NCC and NDMC will provide support for the study. • The opportunity is open to various types of organizations, including non-profits, universities, and small businesses. • The application deadline is November 19, 2026.